BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28378640)

  • 1. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma.
    Karimkhanloo H; Mohammadi-Yeganeh S; Ahsani Z; Paryan M
    Tumour Biol; 2017 Apr; 39(4):1010428317698361. PubMed ID: 28378640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma.
    Karimkhanloo H; Mohammadi-Yeganeh S; Hadavi R; Koochaki A; Paryan M
    Mol Biol Rep; 2020 Oct; 47(10):7429-7437. PubMed ID: 32901357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma.
    Ahsani Z; Mohammadi-Yeganeh S; Kia V; Karimkhanloo H; Zarghami N; Paryan M
    Appl Biochem Biotechnol; 2017 Mar; 181(3):884-897. PubMed ID: 27687586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway.
    Shan X; Miao Y; Fan R; Qian H; Chen P; Liu H; Yan X; Li J; Zhou F
    Int J Mol Sci; 2013 Apr; 14(4):8556-69. PubMed ID: 23598417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.
    Zhang Y; Guo X; Li Z; Li B; Li Z; Li R; Guo Q; Xiong L; Yu L; Zhao J; Lin N
    RNA Biol; 2015; 12(6):643-57. PubMed ID: 25985117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
    Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CTBP1-AS2 Promotes Cell Proliferation in Hepatocellular Carcinoma by Regulating the miR-623/Cyclin D1 Axis.
    Wang M; Zhao H
    Cancer Biother Radiopharm; 2020 Dec; 35(10):765-770. PubMed ID: 32522013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
    Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
    Zhang Y; Zheng L; Ding Y; Li Q; Wang R; Liu T; Sun Q; Yang H; Peng S; Wang W; Chen L
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1132-1140. PubMed ID: 26031366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 15. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
    Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity.
    Zhu L; Gao J; Huang K; Luo Y; Zhang B; Xu W
    Sci Rep; 2015 Nov; 5():16732. PubMed ID: 26567713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
    Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
    J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
    BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.